Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study116

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study55

Views

Views
September 202520
October 20254
November 202511
December 20256
January 202610
February 20260
March 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States24
Brazil14
Finland5
Argentina3
United Kingdom2
Ecuador2
Germany1
Algeria1
Kenya1
Morocco1
 

Top cities views

Views
Dallas16
Helsinki5
San Jose4
Alegrete1
Ayacucho1
Capivari1
Caseros1
Caxias1
Fortaleza1
Frankfurt am Main1